2026-09-16——
Twist Bioscience joins Lilly TuneLab as preferred antibody characterization data provider
A short entry: a summary of the public record, checked against its sources, not yet read and analysed by Gianluca. How the register works
On September 16, 2026, Twist Bioscience announced it has joined Eli Lilly's TuneLab as a preferred antibody characterization data provider, generating high-throughput wet lab antibody characterization data using TuneLab-specified protocols that feed into AbLab, Lilly's antibody developability prediction model. Financial terms were not disclosed.
What happened
- The agreement was announced on September 16, 2026.
- Twist will generate high-throughput wet lab antibody characterization data using TuneLab-specified protocols, feeding into AbLab, Lilly's antibody developability prediction model.
- TuneLab users can order antibody characterization services directly from Twist using preferred protocols.
- Data feeds back into TuneLab through federated learning, in which model updates but not raw proprietary data are shared.
- Lilly launched TuneLab in September 2025, with its initial model release incorporating proprietary data generated through more than USD 1 billion in research investment.
- TuneLab has grown to more than 75 participating companies since launch.
Sources
- investors.twistbioscience.com — primary
- en.wikipedia.org — party background
- investing.com — party background
- allsci.com — party background
Announced 2026-09-16 · Added to the register 2026-09-30